Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chengquan Zhao

Showing results (31-40 of 183) with videos related to

Pageof 19
Sort By:
Journal of Clinical Microbiology|May 8, 2015
Point-Counterpoint: Cervical Cancer Screening Should Be Done by Primary Human Papillomavirus Testing with Genotyping and Reflex Cytology for Women over the Age of 25 YearsMark H Stoler, R Marshall Austin, Chengquan Zhao
American Journal of Clinical Pathology|June 19, 2012
Histologic follow-up in patients with Papanicolaou test findings of endometrial cells: results from a large academic women's hospital laboratoryZaibo Li, Christopher Gilbert, Huaitao Yang, et al.
Obstetrics and Gynecology|August 23, 2018
Quality Improvement to Demonstrate the Lack of Reliability of the Human Papillomavirus mRNA Assay to Identify Women With Latent Human Papillomavirus InfectionsR Marshall Austin, Chengquan Zhao, Dina R Mody
Archives of Pathology & Laboratory Medicine|March 4, 2011
Follow-up findings in young females with high-grade squamous intraepithelial lesion papanicolaou test resultsChengquan Zhao, Pal Kalposi-Novak, R Marshall Austin
Journal of Cancer|April 12, 2011
Pathogenesis of ovarian clear cell adenofibroma, atypical proliferative (borderline) tumor, and carcinoma: clinicopathologic features of tumors with endometriosis or adenofibromatous components support two related pathways of tumor developmentChengquan Zhao, Lee Shu-Fune Wu, Ross Barner
Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology|December 26, 2015
[New markers for diagnostic and prognostic evaluation of ovarian clear cell carcinoma]Xiang Tao, Weiyong Gu, Xianrong Zhou, et al.
Acta Cytologica|January 13, 2012
Histopathologic outcomes and clinical correlations for high-risk patients screened with anal cytologyChengquan Zhao, Akosua B Domfeh, R Marshall Austin
Archives of Pathology & Laboratory Medicine|July 31, 2010
Significance of high-risk human papillomavirus DNA detection in women 50 years and older with squamous cell papanicolaou test abnormalitiesChengquan Zhao, Shuping Zhao, Amer Heider, et al.
The American Journal of Surgical Pathology|January 27, 2007
Comparative analysis of alternative and traditional immunohistochemical markers for the distinction of ovarian sertoli cell tumor from endometrioid tumors and carcinoid tumor: A study of 160 casesChengquan Zhao, Gary L Bratthauer, Ross Barner, et al.
Archives of Pathology & Laboratory Medicine|December 9, 2008
Adjunctive human papillomavirus DNA testing is a useful option in some clinical settings for disease risk assessment and triage of females with ASC-H Papanicolaou test resultsSudeshna Bandyopadhyay, R Marshall Austin, David Dabbs, et al.
Pageof 19

Showing results (31-40 of 183) with videos related to

Sort By:
Pageof 19
Journal of Clinical Microbiology|May 8, 2015
Point-Counterpoint: Cervical Cancer Screening Should Be Done by Primary Human Papillomavirus Testing with Genotyping and Reflex Cytology for Women over the Age of 25 YearsMark H Stoler, R Marshall Austin, Chengquan Zhao
American Journal of Clinical Pathology|June 19, 2012
Histologic follow-up in patients with Papanicolaou test findings of endometrial cells: results from a large academic women's hospital laboratoryZaibo Li, Christopher Gilbert, Huaitao Yang, et al.
Obstetrics and Gynecology|August 23, 2018
Quality Improvement to Demonstrate the Lack of Reliability of the Human Papillomavirus mRNA Assay to Identify Women With Latent Human Papillomavirus InfectionsR Marshall Austin, Chengquan Zhao, Dina R Mody
Archives of Pathology & Laboratory Medicine|March 4, 2011
Follow-up findings in young females with high-grade squamous intraepithelial lesion papanicolaou test resultsChengquan Zhao, Pal Kalposi-Novak, R Marshall Austin
Journal of Cancer|April 12, 2011
Pathogenesis of ovarian clear cell adenofibroma, atypical proliferative (borderline) tumor, and carcinoma: clinicopathologic features of tumors with endometriosis or adenofibromatous components support two related pathways of tumor developmentChengquan Zhao, Lee Shu-Fune Wu, Ross Barner
Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology|December 26, 2015
[New markers for diagnostic and prognostic evaluation of ovarian clear cell carcinoma]Xiang Tao, Weiyong Gu, Xianrong Zhou, et al.
Acta Cytologica|January 13, 2012
Histopathologic outcomes and clinical correlations for high-risk patients screened with anal cytologyChengquan Zhao, Akosua B Domfeh, R Marshall Austin
Archives of Pathology & Laboratory Medicine|July 31, 2010
Significance of high-risk human papillomavirus DNA detection in women 50 years and older with squamous cell papanicolaou test abnormalitiesChengquan Zhao, Shuping Zhao, Amer Heider, et al.
The American Journal of Surgical Pathology|January 27, 2007
Comparative analysis of alternative and traditional immunohistochemical markers for the distinction of ovarian sertoli cell tumor from endometrioid tumors and carcinoid tumor: A study of 160 casesChengquan Zhao, Gary L Bratthauer, Ross Barner, et al.
Archives of Pathology & Laboratory Medicine|December 9, 2008
Adjunctive human papillomavirus DNA testing is a useful option in some clinical settings for disease risk assessment and triage of females with ASC-H Papanicolaou test resultsSudeshna Bandyopadhyay, R Marshall Austin, David Dabbs, et al.
Pageof 19